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Abstract Introduction and objectives. This study aims to investigate whether the cerebral 
modifications of posttraumatic reactive astrocitose can be considered an objective criterion for 
determining the age of traumatic cranio-cerebral lesions.  
Materials and methods. The present study consists of a series of 23 medico-legal cases that 
underwent autopsy in Teleorman County (Romania) Department of Forensic Medicine during 
2007–2016, with full immune-histochemical microscopic examination using GFAP staining. The 
study consists of two groups, a series of 13 cases with cranio-cerebral trauma with different 
posttraumatic survival periods and 9 cases as a control group.  
Results and discussions. We discovered GFAP+ reactive astrocytes even when death 
occurred immediately after the trauma event and up to 4 months after the traumatic incident. We 
also discovered an intense positive correlation between the density of the GFAP+ cell from the 
perilesional area and the posttraumatic survival period. The highest cerebral density of the 
GFAP+ astrocytes occurred with acute death prior (1 to 24 hours) and the lowest in the chronic 
period (over 2 weeks).  
Conclusions. The gradual and differentiated appearance of the reactive astrocytes in close 
relation with the cerebral posttraumatic interval, with specific lesional and perilesional 
distribution as well as in surrounding area, clearly demonstrates that the state of the reactive 
astrocitose may constitute an objective index for evaluation of the elapsed time after the 
posttraumatic event.     
  












Highlights ✓ The gradual and differentiated development of the reactive astrocytes in close relationship 
with the time from the main trauma event, with specific lesional, perilesional, and far area 
distribution demonstrates that studying the reactive astrocitose process can constitute as 
an objective index for evaluating the posttraumatic elapsed time.  
✓ The reaction of the glial cells plays a significant role in the development of cranio-cerebral 
lesions     
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Introduction 
Astrocytes are the most known neuroglial 
components, being five times denser than neurons and 
being a common part of the central nervous system of 
all vertebrates. Reactive astrocitose is a specific process 
in which the astrocytes respond to all cerebral lesions, 
being a result of structural lesions upon the central 
nervous system. Reactive astrocitose consists of a broad 
range of astrocyte transformations, starting with 
reversible gene expressions or light cellular hypertrophy 
with integrity of the tissue and cell internal architecture 
and ending up with definitive glial scar construction 
through rearrangement of the cerebral histological 
elements. The immuno-histochemical study of the glial 
fibrillar acid protein (GFAP) expression is used as a 
typical marker for identifying the reactive astrocytes, 
other molecular markers used for this immune-
histochemical determination being glutamin-systethase 
and S100ß (1, 2). The utility of these markers is 
nevertheless limited because, in contrast to the GFAP, 
they are not specific to astrocytes cells. GFAP is an 
extremely stable fibrillar intermediate protein, being 
also an essential structural component of the astrocyte 
cell internal cytoskeletal structure that, under normal 
physiological conditions, cannot be found dispersed in 
the cytoplasmic fluid. Also, GFAP cannot be detected 
through immune-histochemical techniques in non-
reactive astrocytes. Experimental studies have shown 
that GFAP is not essential for normal physiological 
functions of the astrocyte cell, but it is important in 
reactive astrocitose processes and for glial scar 
development (3, 4). 
This study investigates whether the use of immune-
histochemical techniques with GFAP staining for 
cerebral modifications of reactive astrocitose can 
constitute an objective criterion for determining the age 
of traumatic cranio-cerebral lesions. 
 
Material and method     
This study analyzed the autopsy cases performed in 
Teleorman County, Romania, Department of Forensic 
Medicine from 2007–2016. It includes a retrospective 
observation between 2007 and 2014 and a prospective 
study between 2015 and 2016. Of the entire lot of 
autopsies performed, we selected 22 cases for 
microscopic evaluation, with 2 sub-batches. The first lot 
included 13 cases with deaths from posttraumatic 
cranio-cerebral lesions, with variable survival times, 
ranging from instant death up to 4 months survival time. 
All selected cases had a violent pattern of trauma onset 
(4 physical aggressions, 6 road accidents, 1 free fall, 1 
fall within the same height, and 1 case of undetermined 
conditions). We did not include those cases with 
neurosurgical postoperative lesions, as various 
postoperative conditions could have interfered with the 
initial macro- and microscopical cerebral lesions. Based 
on posttraumatic survival times, these cases were further 
divided into 4 categories: 
- Death within the supra-acute period, of seconds and 
minutes and up to hours from the initial trauma event: 3 
cases; 
- Death within the acute period, ranging form1 hour and 
up to 24 hours after the trauma event: 3 cases; 
- Death within the sub-acute period, ranging from 1 day 
and up to 14 days: 3 cases; 
- Death during the chronic period, after 2 weeks post 
trauma: 4 cases. 
A second lot consisted of 9 cases selected for 
comparison as a control group, with no cranio-cerebral 
events and no cerebral lesions detected during autopsy. 
We did not include in this lot cases with known cerebral 
vascular diseases. These cases had both violent (5 cases) 
and non-violent (4 cases) mechanisms of death onset 
from the following: mechanical asphyxia through 
strangulation, phosphorous-organic acute intoxication, 
underwater mechanical asphyxia, hypothermia, 
myocardial fibrosis, acute myocardial infarction, 
pulmonary thromboembolism, toxic-septic shock, and 
electrocution. 
• Techniques employed by the study 
For each case, we harvested during autopsy cerebral 
tissue samples of approx. 3 by 2 cm that were later 
immersed in fixation dye based on a 10% buffered 
formalin solution and hermetically sealed in recipients 
should this be receptacles? with a 5 times larger volume 
of formalin solution than the tissue mass, for a period of 
2 weeks. The tissue samples were later embedded in 
paraffin blocks, each of them with 3 serial sections of 
1.5-2 µm thickness. These sections were stripped of 
paraffin and rehydrated and dyed using a standard 
Hematoxilin-Eozine (HE) staining. The final step 
consisted of a manual technique for immuno-
histochemical staining. 
For the GFAP-revealing immune-histochemical 
staining, we employed the following steps: as a first 
measure we blocked the intrinsic peroxidase activity by 
treating the sections with Peroxidazed-1 for 5 minutes at 
room temperature. Then, the revealing of the GFAP 
antigen was achieved by the Heat Induced Epitope 
Retrieval method (HIER) with boiling at 950C for 45 
minutes with the aid of a Decloaking Chamber. 
Blocking of the non-specific staining was achieved by 
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treating the sections with Background Sniper solution 
(Biocare Medical©) for 10 minutes at room temperature. 
Applying the primary GFAP(M) antibody was achieved 
by delivering the GA-5 clone mice-produced 
monoclonal anti-GFAP(M) antibody on the sections 
(Biocare Medical©) with the factory recommended 
dilution of 1:100 for 60 minutes at room temperature. 
Detection of the probe/polymer was achieved by 
applying first the probe for 10 minutes then the universal 
polymer for 20 minutes. The antibodies were identified 
by means of the MACH 4 Universal HRP-Polymer 
detection system (Biocare Medical©) which can detect 
both anti-rabbit and anti-mice antibodies. After each of 
these steps, the blades were washed with buffer solution 
with a pH of 7.6 (TBS Plus, by Biocare Medical©). 
Applying the DAB chromogen was achieved by fixing 
the blades Betazoid DAB solution (Biocare Medical©) 
for 2 minutes at room temperature. Later, we washed 
them for 1 minute with deionized water and after this 
step the overcoloring was done with CUT Hematoxylin, 
followed by dehydration, clarifying, and mounting the 
sections on the final lamellas.  
• Microscopical examination 
Brain fragments were examined with light 
microscopy and different magnifying lenses provided by 
the Leica ICC 50W transmitted light microscope with an 
attached photography kit. For the cranio-cerebral trauma 
cases, we performed a regional quantitative analysis of 
the GFAP-positive cells determining the final mean 
number of cells at the level of lesion, adjacent area, and 
far surroundings. Two independent observers each 
analyzed 5 microscopic fields with a 20x lens for 3 
blades of the same case by employing a standard 
viewport grill and therefore obtaining the mean number 
of GFAP-positive cells distributed at the level of the 
lesion, the adjacent zone, and the far surrounding area. 
We report them as an arithmetic mean between the 
determinations of each case. The final number of GFAP-
positive cells for the corresponding areas was 
determined as a mean computation between the figures 
reported by the two independent observers. The GFAP-
positive cell density at the level of each area was 
determined by reporting the final mean number of cells 
per square mm of brain tissue. 
• Statistical analysis 
Data were parsed with the SPSS analysis software 
(SPSS for Microsoft Windows, ver. 17.0). Statistical 
analysis focused on brain density of the GFAP-positive 
cells, as a continuous variable, described both globally 
as well as on layers, on subgroups of interest, by the 
central trend (mean, median) and dispersion (standard 
deviation). During the analytical stage, comparison of 
the subgroups and validation of the hypothesis were 
achieved using the t-test for independent samples and 
with the non-parametric Mann-Witney U test when the 
assumption of a normal distribution was not met. 
ANOVA as well as the non-parametric Kruskal-Wallis 
test were used for establishing differences between 
various parameters within the studied groups. 
Differences between the 2 lots of cases were considered 
significant using p of 0.05. Data were then transformed 
into standard graphical representations. 
 
Results 
In the supra-acute posttraumatic period, we detected 
GFAP-positive cells with light to moderate hypertrophy. 
During the acute, sub-acute, and chronic intervals, the 
GFPA-positive astrocytes developed severe 
hypertrophy. Development of the glial scars was noted 
starting with 1 to 2 months after the trauma event. 
During the supra-acute post-traumatic period for the 
GFAP-positive astrocytes with light hypertrophy, GFAP 
staining was observed mostly in the body of the 
astrocytes, and lighter at the outer limits of the cells. As 
for the GFAP-positive astrocytes with moderate 
hypertrophy, GFAP staining was immuno-
histochemically present at both the body of the cell (that 
looks inflated) as well as in the outer limits of the cells 
that appear thickened. (Figure 1, Figure 2, A-B). 
 
  
Figure 1. Immediate posttraumatic death. A, B: 
(lesional/perilesional), low immunopositivity 
reaction of the GFAP-positive staining with growth 
of the GFAP+ cells at the lesional and perilesional 
levels; astrocytes slightly hypertrophic in aspect, 
mostly in the body of the cells, extensions of the 
astrocytes with a filament-like aspect. At 25 
minutes posttraumatic: C (lesional-perilesional), 
D (perilesional) – positive reduced immunoreaction 
of GFAP+ with a light hypertrophy aspect of the 
astrocyte, ballooning of the cell body with thin 
cellular extensions and a perineuronal tree-like 
aspect in the areas of ischemic perilesional zones. 
Roxana-Maria Duncea-Borca et al. 
112 
 
Figure 2. At 45 minutes posttraumatic: A (lesional-
perilesional), B (perilesional) moderate immuno-
positivity of the GFAP reaction with multiple astrocyte 
cells moderately hypertrophied, both a lesional and 
perilesional levels, with an 8-times growth in volume 
of the cell body and cell extension thickening, without 
any astrocyte overlapping. At 1 hour posttraumatic: 
C, D (perilesional) moderate GFAP positive reaction, 
moderate hypertrophy of the astrocyte cells, cell body 
with an increased volume and with numerous 
thickened cell extensions, rare overlapping zones. At 3 
hours posttraumatic: E (lesional), F (perilesional) a 
high positive reactivity of the GFAP reaction, 
numerous astrocytes with moderate hypertrophy, cell 
body with a considerable volume growth and thickened 
cell extensions with lots of overlapping zones (F). 
 
Fig. 3. At 6 hours posttraumatic: A (lesional), B 
(lesional-perilesional) an increased immuno-positivity  
of the GFAP reaction, numerous GFAP-positive  
 
 
astrocyte cells at the perilesional level. GFAP-positive 
astrocytes presented severe hypertrophic 
modifications, cell body with increased volume, 
thickened cell extensions, rare areas of overlapping. At 
1 day posttraumatic: C, D (perilesional) an increased 
immunopositivity of the GFAP reaction, severe 
astrocyte hypertrophy, fragmentation of the astrocyte 
cells, increased cell volume that appears separated 
from the adjacent cell extensions. At 6 days 
posttraumatic: E (lesional-perilesional), F 
(perilesional) an increased immunopositivity of the 
GFAP reaction, low GFAP-positive cell density, 
especially at the lesional level. Astrocytes with severe 
hypertrophic modifications, increased volume of the 
body, multiple thickened extensions, lots of 
overlapping astrocyte areas. 
During the acute and sub-acute posttraumatic 
periods at the level of astrocytes with severe 
hypertrophy, GFAP staining revealed a volumetric 
growth of the body and outer limits of the astrocytes as 
well as fragmentation of the astrocyte pseudopods 
(ranging from light fragmentation during the acute 
period to severe fragmentation in the sub-acute timing) 
(Figure 2: C and D; Figure 3; Figure 4: A and B). 
 
 
Figure 4. At 8 days posttraumatic: A, B (lesional) 
an increased immunopositivity of the GFAP reaction, 
a reduced number of GFAP-positive cells with 
alteration of the cellular morphology, cell body with 
a very large volume that appears separated from the 
astrocyte extensions. At 2 weeks posttraumatic: C, 
D (lesional) an increased immunopositivity of the 
GFAP reaction, with severe hypertrophy and 
morphological alterations of the cell body, extended 
lesions of cell fragmentation, dispersed aspect of the 
body and cell extensions. 
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Figure 5. At 1 month posttraumatic: A (lesional-
perilesional), B (lesional) an increased 
immunopositivity of the GFAP reaction, numerous 
GFAP-positive astrocyte cells at the perilesional level, 
cell body with increased volume, thickened cell 
extensions, severe reactive astrocytosis with glial scar 
formation. At 2 months posttraumatic: C, D 
(lesional) laminar necrosis with gliosis, an increased 
immunopositivity of the GFAP reaction, severe 
hypertrophy, many overlapping areas of the cell 
extensions and forming of extended glial scars. At 4 
months posttraumatic: E, F (lesional-perilesional) 
an increased immunopositivity of the GFAP reaction, 
a reduced number of GFAP-positive cells with 
alteration of the cellular morphology, numerous 
astrocyte bodies separated by astrocyte extensions and 
many overlapping areas 
During the chronic posttraumatic survival period, 
we noticed severe astrocyte hypertrophy, the body of the 
cells being overinflated with numerous thickened 
extensions and overlapping of the pseudopods, thus 
creating glial scars (Figure 4- C and D; Figure 5). The 
GFAP-positive astrocyte response observed in most of 
the control cases was diffuse in the brain tissue, with 
light hypertrophy of the cell`s body, without any 
hypertrophic modifications of the astrocyte extension 
and with no fragmentation or overlapping of the 
astrocyte pseudopods (Figure 6). In only one case from 
the control group did we notice severe reactive 
astrocitose, a high number of GFAP-positive cells being 
present in the perivascular area with a diffuse 
disposition indicating a general glial reaction, a 
characteristic for a toxic encephalitic process? 
Statistical analysis on the density of the GFAP-
positive brain cells revealed significant effects (p < 0.05) 
between the two groups. The density of the brain GFAP-
positive cells was higher in both the amplitude and in the 
central trend for the cases in the study group (that 
included the cranio-cerebral trauma cases with variable 
posttraumatic survival times) compared to the control 
group (that showed a history of cranio-cerebral trauma 
with different causes for death) (Chart 1).  
 
Fig. 6. Analysis of the control group. Reduced 
intensity of the immunohistochemical GFAP staining, 
rare astrocytes with light hypertrophy and diffuse 
dispersion in the brain tissue, a slightly larger cell body 
with lots of thin cell extensions in the case of organo-
phosphorus intoxication (A), pulmonary 
thromboembolism (B) and strangling (C). Moderate 
GFAP staining, moderate cell count and slight 
hypertrophy with homogenous dispersion, ballooning 
of the cell body with filament-like astrocyte 
pseudopods in myocardial-fibrosis (D) and 
hypothermia (E). Moderate GFAP reaction, increased 
expression of the GFAP-positive cells with light 
hypertrophy in diffuse focal arrangement near the blood 
vessels in electrocution (F). A balloon-like cell body 
with thin cell extensions with no overlapping areas of 
the astrocytes. 
Chart 1. The variation of GFAP-positive cerebral 
cell density between the 2 groups. 
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In the immediate posttraumatic death and up to 25 
minutes of survival time after the trauma event, we 
noticed the same density of GFAP-positive cells (25 
cells per square mm of brain tissue), with a doubling at 
the 45 minutes and 1-hour posttraumatic marks. At the 
3-hour posttraumatic survival mark, we recorded the 
highest density of GFAP-positive cells, at 78 cells per 
square mm of brain tissue, followed by a steep decline 
in density at 6 hours posttrauma with a 38 cell per 
square mm value, followed by a slow descent of up to 1 
month after the traumatic event, with a count of 15 cells 
per square mm of brain tissue. 
At the two-month posttraumatic mark, we 
registered a slight elevation in GFAP-positive cell 
density at both lesional and peri-lesional level, with 24 
cells per square mm. At 4 months of posttraumatic 
survival time we noticed the lowest GFAP-positive 
brain cells density (Chart 2). 
 
Chart 2. The variation of GFAP-positive cerebral 
cell density in connection with the survival 
posttraumatic time between the 2 groups. 
 
At 3-hours posttraumatic index, the study revealed 
the highest density of GFAP-positive cells at both 
lesional and peri-lesional levels, of about 35 cells per 
square mm and 40 cells per square mm of brain tissue. 
At 4 months, no GFAP-positive cells were seen at the 
lesional level, this being their lowest density. Between 
1 and 4 months posttrauma, we also noticed a reduced 
density of GFAP-positive cells at the level of the lesion, 
with values ranging from 2 to 5 cells per square mm of 
brain tissue. 
The GFAP-positive cells situated far from the 
cerebral lesions were not detected during the first hour 
following the trauma event. The highest density of 
GFAP-positive cells situated away from the lesional 
site was recorded at 4 months post trauma, with 9 cells 
per square mm of brain tissue (Chart 3). 
 
Chart 3. The variation in density of GFAP-
positive cerebral cells lesional/perilesional in 
regards with the posttraumatic survival time. 
Legend: GFAP+L: GFAP+ lesional cells; 
GFAP+P: GFAP+ perilesional cells; GFAP+D: 
GFAP+ cells at the outer limits of the lesional 
area. 
Regarding the lesional area, the density of GFAP-
positive cells at the site of the lesion and adjacent area 
was significant larger (p = 0.0221 and 0.0277 
respectively) compared with those situated farther 
away.    
The maximum values for GFAP-positive cells 
occurred at the perilesional site (median of 17.08 cells 
per square mm of brain tissue) followed by GFAP-
positive cells at the lesional site (median of 11.92 cells 
per square mm of brain tissue); the lowest value was 
recorded for GFAP-positive cells being the farthest 
away from the lesion (median of 3 cells per square mm 
of brain tissue) (Table 1). 
If the analysis examines the lesional area and the 
period of death, the density of GFAP-positive cells 
differs significantly in comparison to the lesional site 
situated far away (p = 0.005).  
The maximum density of GFAP-positive cells from 
the level of the lesion was encountered during the sub-
acute death. The maximum density of the GFAP-
positive cells at the perilesional area occurred during 
the acute death, and the lowest during the sub-acute 
death.  
In the case of the supra-acute, acute, and sub-acute 
death, perilesional GFAP-positive cells were closer to 
the outer limits, with each statistically significant (p = 
0.0462, 0.0023 and 0.0151 respectively) (Table 1). 
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Period of  
Death Onset 












N 3 3 3 




N 3 3 3 





N 3 3 3 





N 4 4 4 
Median 6,75 5,00 6,00 
p (p=0.176) (p=0.005) (p=0.005) 
Total N 13 13 13 
Median 11.92 17,08 3,00 
Table 1. Comparison between the cerebral 
density of the GFAP-positive cells in regards with 
the lesional area and the elapsed posttraumatic 
time. 
Regarding the lesional area and the posttraumatic 
survival time, results showed a strong positive 
correspondence between the cerebral density of GFAP-
positive cells from the lesional, perilesional, and outer 
limits as well as negative correspondence between the 
cerebral densities of the GFAP-positive cells from the 
perilesional and the outer limit areas. 
In the control group with cranio-cerebral lesions, 
the GFAP-positive cells placed at the outer limits of the 
lesional points, density was directly related with 
survival posttraumatic time; the greater the density, the 
longer was the time. 
 
Discussions 
Experimental studies conducted on mice by 
Kalayci and Woiciechowskyha have identified specific 
modifications of reactive astrocytosis beginning with 
the 24-hour posttraumatic marker, consisting in a 
hypertrophic astrocyte reaction with a maximum at 3-4 
days post trauma. These researchers also showed that 
diffuse cranio-cerebral trauma can lead to light 
astrogliosis with moderate diffusion, the GFAP-
positive astrocytes presenting different grades of 
hypertrophy, without registering losses in the fields of 
the astrocytes and without the constitution of glial scars 
(5, 6). 
The studies of Zhonghua et al., based on the 
experimental induction of lesions at the cerebral trunk 
in mice, revealed typical reactive astrocytosis 
beginning at 15 minutes and up to 15 days post-trauma. 
The first reactive astrocytosis modifications recorded at 
15 minutes consisted in bloating of the astrocyte cells 
with reduced immunopositivity of GFAP staining. 
Between 1 and 3 hours post trauma, the astrocytes 
displayed significant hyperplasic modifications, and 
between the 1-hour to 6-hour markers, the study showed 
astrocyte hyperplasic with moderate hypertrophy, with 
a relatively low intensity of the staining. Between 24-
hours and 96-hours, an elevated number of moderate 
hypertrophic astrocytes and a high intensity of the 
staining were evident. Between 10 to 15 days after the 
trauma, their study revealed both hypertrophy and 
hyperplasic processes, with the most intense coloration 
of the GFAP staining (7). 
Haussman et al. have investigated the 
immunohistochemical reactions of the reactive 
astrocytosis processes that take place in the brain tissue 
in the first 30 weeks after a traumatic event. Between 
the 1st day and the 4th week, numerous GFAP-positive 
hypertrophic astrocytes were found in the surrounding 
areas of some cortical brain concussions (8). 
Summarizing the results of the experimental data 
regarding the reactive astrocytosis process with the aid 
of the GFAP staining, we can conclude that the earliest 
presence of the GFAP-positive cells is 15 minutes after 
a trauma event and this lasts up to a month posttrauma. 
In this study we identified GFAP-positive astrocyte 
cells immediately after death and up to 4 months after 
the traumatic event, with direct correlations between the 
brain density of the GFAP-positive hypertrophic 
astrocytes and the posttraumatic time lapsed, in the first 
3 hours a progressive growth of the GFAP-positive 
brain cells with a later slight downturn in their numbers 
up to the 4-month marker. 
The majority of the published experimental data 
regarding the reactive astrocytosis processes has 
revealed an increased expression of the GFAP-positive 
cells at the lesional and peri-lesional level, but none of 
those studies investigated the reactive astrocitose 
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phenomenon in the outer limits areas, away from the 
initial brain injuries (9). 
This study revealed that the GFAP-positive cells 
are mostly located at the lesion site and the perilesional 
areas, with a reduced density in the outer limits of the 
brain injury. We also noticed a strong positive 
correlation between the GFAP-positive cell density 
from the perilesional areas and the outer limits in close 
relationship with the posttraumatic survival time of the 
case.  
Conclusions 
The study of the reactive astrocitose processes in 
the cranio-cerebral trauma, investigated through GFAP 
immunohistochemical staining, has identified a broad 
spectrum of astrocyte cell transformations in close 
relationship with the posttraumatic elapsed time. 
During the supra-acute period, the study revealed light 
hypertrophic and moderate astrocitose processes with a 
reversible potential, along with a growth in volume of 
the cell body as well as the cell extensions, variable 
fragmentation of the astrocyte pseudopods, without 
altering of the tissue architecture. During the acute, sub-
acute, and chronic post-traumatic periods, the study 
revealed irreversible modifications consisting of severe 
hypertrophy with numerous areas of astrocyte 
overlapping and glial scar developing along with 
rearranging of the brain histological elements beginning 
with 1 month and up to 2 months posttrauma. The 
highest cerebral density of the GFAP-positive 
astrocytes was noticed in the acute period of death (1 to 
2 hours) and the lowest in the chronic period (over 2 
weeks). 
The gradual and differentiated development of the 
reactive astrocytes in close relationship with the time 
from the main trauma event, with specific lesional, 
perilesional, and far area distribution demonstrates that 
studying the reactive astrocitose process can constitute 
as an objective index for evaluating the posttraumatic 
elapsed time. 
The reaction of the glial cells plays a significant 
role in the development of cranio-cerebral lesions, 
during the early stage (when the clinical landscape is 
dominated by the primary traumatic lesions) and also 
during the late stage (when the clinical evolution is 
influenced mostly by the secondary cerebral injuries).  
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